News | Population Health | October 18, 2019

New Registry to Provide Insight into STEMI Occurrence, Treatment in North India

First prospective cohort study of this magnitude in the region already providing unique data about opportunities to improve STEMI management in India

New Registry to Provide Insight into STEMI Occurrence, Treatment in North India

Image courtesy of UNC School of Medicine


October 18, 2019 — A new study published in Clinical Cardiology[1] introduces the North Indian (NORIN) ST‐Segment Elevation Myocardial Infarction (STEMI) Registry and provides preliminary data collected since its start in January of this year. The prospective cohort study’s first author, Sameer Arora, M.D., UNC School of Medicine cardiology fellow and preventive medicine resident, says researchers will follow approximately 3,500 patients admitted for STEMI treatment to two government-funded medical centers in New Delhi, India.

These hospitals serve a large proportion of the patients with lower socioeconomic status presenting from multiple states in India, as many centers in these states lack adequate specialized cardiovascular care. The NORIN STEMI registry aims to provide important insights regarding contemporary risk factors profiles, practice patterns and prognosis in patients with STEMI in an underserved population in North India. These findings may identify opportunities to improve the outcomes of patients with STEMI in the country.

From January through March of this year, 558 patients were registered in the study. Preliminary data from those patients is already providing insight into this population that has not been available previously.

“We have found that only 14 percent of patients being treated for STEMI at these hospitals are women, which is much lower than the average number of women having this kind of heart attack in the United States,” Arora said. “We suspect 14 percent is also lower than the actual average of women having STEMI in North India, but we need to understand why more women aren’t making it to the hospital for treatment.”

Researchers have also found the average age of STEMI patients in this study is nearly ten years younger than the average age of patients in Europe and the U.S. About a third of the patients are less than 50 years old. Arora says this is exactly the kind of information that will provide more insight into population health in that region and help improve treatment for STEMI.

Throughout the course of the study, researchers will follow up with patients several times within one year of their initial treatment for STEMI. The study is currently un-funded.

For more information: www.onlinelibrary.wiley.com

Reference

1. Arora S., Qamar A., Gupta P., et al. Design and rationale of the North Indian ST-Segment Elevation Myocardial Infarction Registry: A prospective cohort study. Clinical Cardiology, published online Oct. 8, 2019. https://doi.org/10.1002/clc.23278

Related Content

News | Cardiovascular Clinical Studies

August 17, 2022 — A study carried out by scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) ...

Home August 17, 2022
Home
News | Cardiovascular Clinical Studies

August 12, 2022 — Older adults with atrial cardiopathy (a major, often undetected cardiac cause of stroke) may be at ...

Home August 12, 2022
Home
News | Cardiovascular Clinical Studies

August 8, 2022 — Two years ago, University of Alabama at Birmingham researchers and colleagues reported that reductive ...

Home August 08, 2022
Home
News | Cardiovascular Clinical Studies

July 22, 2022 — BioSig Technologies, Inc. a medical technology company advancing electrophysiology workflow by ...

Home July 22, 2022
Home
News | Cardiovascular Clinical Studies

July 18, 2022 — scPharmaceuticals Inc., a pharmaceutical company focused on developing and commercializing products that ...

Home July 19, 2022
Home
News | Cardiovascular Clinical Studies

July 15, 2022 — Imagine, if scientists had a map of the heart, so granular in its accuracy that it even profiled details ...

Home July 15, 2022
Home
News | Cardiovascular Clinical Studies

July 11, 2022 — Smoking traditional or non-combustible cigarettes while wearing a surgical mask results in a two-fold ...

Home July 12, 2022
Home
News | Cardiovascular Clinical Studies

June 24, 2022 — Henry Ford Health was part of a multi-institutional heart failure study that was launched and executed ...

Home June 24, 2022
Home
News | Cardiovascular Clinical Studies

June 21, 2022 — Renibus Therapeutics (“Renibus”), a clinical-stage biotech company focusing on the prevention and ...

Home June 21, 2022
Home
News | Cardiovascular Clinical Studies

June 13, 2022 — Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that ...

Home June 13, 2022
Home
Subscribe Now